ResMed (RMD)

EBITDA Margin

38.33%

TTM · Period ending:

RMD logo

RMD EBITDA Margin

Latest reported38.33%
RMD TTM EBITDA Margin (9.09% → 38.33%)
High-resolution chart · PNG

RMD ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

ResMed EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
38.3332%
39.6485%
38.5621%
37.9315%
37.3794%
34.9232%
35.0842%
34.1592%
32.8704%
33.1393%
31.7901%
31.3897%
31.8654%
32.1957%
32.3956%
32.4972%
32.8841%
33.2881%
33.8627%
34.3924%
34.6214%
35.0478%
34.8025%
34.0831%
33.1496%
29.891%
28.6992%
28.2985%
27.7534%
30.0412%
30.0039%
29.6343%
29.0669%
28.4714%
27.9826%
26.6091%
26.4424%
26.5714%
26.3896%
27.9776%
28.4283%
27.88%
28.354%
27.2836%
27.6026%
30.2584%
30.6072%
32.2724%
32.8406%
32.3437%
32.3099%
31.6761%
31.0201%
32.6652%
32.0441%
31.5357%
30.8061%
26.3965%
26.0097%
26.3177%
27.1522%
27.9528%
28.4609%
28.1383%
27.6417%
28.1313%
26.9848%
26.4976%
25.5055%
23.3512%
23.9609%
23.8943%
24.5192%
25.5802%
18.1799%
17.4272%
16.132%
16.5517%
23.9252%
25.3677%
26.8905%
27.2646%
30.0281%
30.8564%
32.1733%
32.3843%
30.2453%
28.1361%
26.4798%
25.1823%
26.3678%
27.8929%
29.1783%
-11.9311%
-14.9312%
-17.5821%
-20.0107%
29.1675%
31.1224%
31.1792%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.